The global Tylosin Market, by Drug Type (Tylosin Phosphate, Tylosin Tartrate, and Others), by Application (Felines, Canines, and Livestock), by Route of Administration (Oral and Injectable), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 379.0 million in 2017, and is projected to exhibit a CAGR of 1.2% over the forecast period (2018 – 2026). Availability of wide number of therapeutic options, and dosage strengths, antimicrobial efficacy and effectively, high prevalence of infectious diseases, and increasing demand for livestock is expected to fuel growth of the global Tylosin market.
Tylosin is available under brand
names such as Tylan (Tylosin Phosphate) by Elanco, Tylovet (Tylosin Phosphate)
by Huvepharma, Tylan Soluble (Tylosin Tartrate) by Elanco, and others. The
demand for antibiotics for against infection in livestock is on the rise, owing
to increasing need for healthy livestock for human consumption. Antibiotics
such as tylosin are used against mycoplasmosis in several animals such as
chickens, turkeys, pigs, and calves. Tylosin is administered orally in required
dosage in order to prevent said infections and to grow healthy livestock.
Manufacturers such as Elanco Animal Health, Zoetis, Tairui Pharmaceuticals,
AdvaCare Pharma, and another offer tylosin in various forms such as active
pharmaceutical ingredient and solid dosage form and is generally available in
veterinary soluble powder and granule forms.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2061
The U.S. Food & Drug
Administration (FDA) approved new combination uses of Zoetis feed additives
ACTOGAIN 45 (ractopamine hydrochloride) and Engain (ractopamine hydrochloride)
in 2015. ACTOGAIN 45 can be used with Rumensin (monensin USP) plus Tylovet 100
(tylosin phosphate). Browse 17 Market Data Tables and 20 Figures spread through
147 Pages and in-depth TOC on Tylosin Market, by Drug Type (Tylosin Phosphate,
Tylosin Tartrate, and Others), by Application (Felines, Canines, and
Livestock), by Route of Administration (Oral and Injectable), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
Global Forecast to 2026
Manufacturers are focused on
adopting various strategies such as participation in events and meets, raising
awareness about animal health, and marketing activities in order to showcase
their products. For instance, Huvepharma participated in Respiratory Health Seminar
for Pig Practitioners that took place in Belgium in 2017. Moreover, the company
held its 5th European seminar: Insights on Nutrition and Health of High
Performing Animals in June 2018. Furthermore, in January 2018, Huvepharma
acquired AgriLabs to expand the company’s presence in the U.S. Moreover, in
2015, Elanco released an eight-point antibiotic stewardship plan to outline
global actions for the company to ensure long-term access to antibiotics for
people and animals.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/tylosin-market-2061
Key Takeaways of the Tylosin
Market:
The global tylosin market is
expected to exhibit a CAGR of 2% over the forecast period (2018 – 2026), owing
to various product offering by leading manufacturers
North America and Europe is
expected to retain dominant position in the Tylosin market over the forecast
period due to presence of leading manufacturers and considerable usage of
tylosin in the livestock industry
Major players operating in the
global tylosin market include, Zoetis, Inc., Tairui Pharmaceuticals, Lukang
Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd,
Huvepharma, AdvaCare Pharma, and Elanco Animal Health.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2061
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
No comments:
Post a Comment